--To the press -
Developed a new AI algorithm to be installed in the AI review tool "KIBIT Automator"
FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)
This AI algorithm is a highly versatile technology that can be installed in various FRONTEO products, including KIBIT Automator, and is expected to contribute to further improving the functionality of our existing products.
■ About KIBIT Automator URL: https://legal.fronteo.com/products/kibit-automator/
"KIBIT Automator" improves the efficiency of document review work in electronic discovery (e-discovery), reduces the burden on workers, and reduces costs, among other discoveries required in the trial proceedings of US civil proceedings. An AI tool developed for the purpose, released in March 2019.We apply the research method used in discovery and utilize AI to examine and analyze large-capacity e-mails and electronic files that are evidence materials.In recent years, it is expected to respond to the short-term information disclosure required of companies.
■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO is a data analysis company that uses the in-house developed AI engines KIBIT and Concept Encoder, Looca Cross specialized in natural language processing to extract meaningful and significant information from a large amount of textual data and support companies' business. Since its inception in August 2003, we have been working globally with Japan, the United States, Korea, and Taiwan, mainly in the Legaltech business, such as e-discovery (electronic evidence disclosure) and digital forensic surveys, which support company international lawsuits. Based on AI technology developed in this project, we have expanded our business fields to life science, business intelligence, and economic security since 8, and have used AI to transform textual data into knowledge, thus contributing to the resolution of various companies' issues, including support for drug discovery, support for dementia diagnostics, and support for financial, human resources, and business. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. In January 6, the company obtained a license to manufacture and sell Class I medical devices (license number: 26B2021X1), and in September of the same year, the company submitted a notification to sell controlled medical devices (notification number: 13MinatoMiSeikikiDai1). Capital: ¥10350 (as of March 9, 3).
* FRONTEO, KIBIT, KIBIT Automator, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.
<Contact information for the press>
PR Department, FRONTEO, Inc.
Email: pr_contact@fronteo.com